- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Five weight-loss media articles were complained about. Novo Nordisk was not responsible for four. One Sunday Times interview quote was ruled promotional…
A third‑party promotional email for Nustendi quoted a “38% LDL‑C reduction (placebo‑corrected)”. The PMCPA ruled the layout implied this was vs ezetimibe…
PMCPA ruled GSK’s “Trevor trusts Trelegy” claim on an HCP website was ambiguous, misleading and unsubstantiated (Clauses 6.1, 6.2, 5.1). No breach…
Complaint alleged Besins Hormone Academy webpages were disguised promotion. Panel found it was clearly a Besins HCP site with PI link and…
CSL Vifor voluntarily admitted breaches after a global team sent a UK HCP an uncertified email invite/flyer for an overseas CKD-aP meeting…
PMCPA ruled AstraZeneca breached Clause 5.5 after a contracted HCP tweeted #speakupforCOPD without declaring their association. Website disclosure was deemed sufficiently prominent;…
PMCPA found Moderna responsible for a senior employee’s policy articles and X reposts. Missing disclosure breached Clause 5.5 and high standards (5.1).…
Complaint alleged Evra ad and linked ‘Benefits’/‘Safety & tolerability’ pages omitted full indication and key risks/contraindications. Panel found no breach of Clauses…
Complaint alleged a COPD therapy review service was misclassified as Joint Working and that software, patient leaflets and consultation summaries weren’t certified.…
A health professional challenged an incorrect Disclosure UK entry showing MSD provided financial support. The Panel found the disclosure inaccurate and misleading,…
ViiV and the PMCPA Director complained that Gilead continued to display a Biktarvy tolerability claim on a UK-accessible website after giving an…
Allergan reposted Instagram Stories and employee posts that included Botox pack shots and an “Injectable Product of the Year” reference. The Panel…
An ex-employee alleged Daiichi-Sankyo grossly underreported conference-related transfers of value on Disclosure UK (2016–2018). The Panel found multiple disclosure and record-keeping breaches,…
Colonis admitted a promotional letter for Melatonin 1mg/ml Oral Solution included prescribing information for Melatonin 3mg tablets. The Panel ruled breaches including…
GSK funded a patient-organisation-hosted taskforce. PMCPA found sponsorship disclosure wasn’t clear “from the outset” because it was only accessible via small footer…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.